Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Research Fellowship: Awardees & Reports

The ESMO Research Fellowship was first introduced in 1989 and is awarded as a one-year project with the option of a second-year prolongation upon request and subsequent approval by the Fellowship Committee. Depending on the focus of the submitted fellowship project young oncologists are offered the following research experience:

  • Focus Translational - Comprehensive bench-to-bedside training providing the opportunity to learn about the latest developments in translational cancer research.
  • Focus Clinical - Training in clinical research in renowned European cancer centres and supports efforts to expand professional networks through collaboration with institutions of excellence

2020

Elisabeth Bergen
bergen-elisabeth

Project: Molecular classification of pancreatic cancer by gene expression analysis of circulating tumor DNA
Home institute: Vienna General Hospital (AKH) - Medizinische Universität Wien, Vienna, Austria
Host institute: Department of Gastroenterology and Gastrointestinal Oncology Department Georges Pompidou European Hospital,  Sorbonne Paris-Cité,  Université Paris-Descartes, Paris, France
Sponsor: ESMO
Start date: September 2020

Luca Cantini
cantini-luca

ProjectENSURE study - Dendritic cell therapy combined with surgery in mesothelioma
Home institute: Università Politecnica delle Marche - AOU Ospedali Riuniti Ancona, Ancona, Italy
Host institute: Erasmus MC Cancer Centre, Rotterdam, Netherlands
Sponsor: ESMO
Start date: January 2021

Giulia Costanza Leonardi
leonardi-giulia-costanza

ProjectThe role of tumor-specific CD8+ T cells in tumor evolution and response to immune checkpoint inhibitors in cervical cancer patients
Home institute: Università degli Studi di Catania, Catania, Italy
Host institute: Cancer Research Center of Toulouse (CRCT, Inserm UMR 1037) and Institut Universitaire du Cancer de Toulouse – Oncopole (IUCT-O), Toulouse, France 
Sponsor: ESMO
Start date: January 2021

Long Nguyen
nguyen-long

ProjectInvestigating the molecular mechanisms that regulate human breast cancer stem cell function in response to systemic therapy
Home institute: Princess Margaret Cancer Centre, Toronto, Canada
Host institute: Cancer Research UK Cambridge Institute, Cambridge, United Kingdom
Sponsor: ESMO
Start date: April 2021

Andri Papakonstantinou
papakonstantinou-andri

Project: Impact of microbiota on breast cancer prognosis and treatment efficacy
Home institute: Karolinska Institutet, Solna, Sweden
Host institute: Vall d’Hebron Institute of Oncology, Barcelona, Spain
Sponsor: ESMO
Start date: January 2021

Francesco Schettini
schettini-francesco

Project: Prognostic and therapeutic significance of treatment-induced intrinsic subtypes and genomic changes in Luminal breast tumors
Home institute: Azienda Ospedaliera Universitaria Federico II, Naples, Italy
Host institute: August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
Sponsor: ESMO
Start date: January 2021

Madeleine Strach
strach-madeleine

ProjectCharacterisation of appendiceal adenocarcinoma by transcriptomic analysis and correlation with clinical outcomes: a step towards rational therapeutics
Home institute: Chris O'Brien Lifehouse, Lilyfield, Australia
Host institute: The Christie Colorectal and Peritoneal Oncology Research Group, Manchester Cancer Centre, Manchester, United Kingdom
Sponsor: ESMO
Start date: August 2021

Francesco Cortiula
cortiula-franscesco

Project: Concurrent chemotherapy and PROton therapy coMpared to photon therapy, followed by Durvalumab maintEnance in sTagE III NOn-Small Cell Lung Cancer (NSCLC) (PROMETEO study): immunological and hematological effects
Home institute: CRO Aviano National Cancer Institute, Udine, Italy
Host institute: Maastricht University Medical Center+, Maastricht, Netherlands
Sponsor: ESMO
Start date: January 2021

Aljosja Rogiers
rogiers-aliosia

Project: A prospective observational study to identify a composite biomarker for prediction and early detection of immunotherapy-related adverse events (irAEs)
Home institute: Melanoma Institute Australia, Sydney, Australia​
Host institute: The Royal Marsden NHS Foundation Trust, London, United Kingdom
Sponsor: ESMO
Start date: June 2021

2019

Gabor Dobos
dobos-gabor

Project: Evaluation of a combination of biomarkers for an early diagnosis of mycosis fungoides
Home institute: Charité - Universitätsmedizin Berlin, Germany
Host institute: Hôpitaux Universitaires, Saint-Louis Lariboisière Fernand-Widal, France 
Sponsor: Roche
Start date: January 2020 (prolonged for the 2nd year)

Eleonora Ghisoni
ghisoni-eleonora

Project: Characterisation of stromal TILs specificity and activity in immune excluded epithelial ovarian cancer
Home institute: Institute for Cancer Research and Treatment of Candiolo- FPO/IRCCS, Italy
Host institute: CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Sponsor: ESMO
Fellowship period: August 2019 – June 2021

Read the publication

Asuka Kawachi-Kawai
kawachi-kawai-asuka

Project: Identification of novel therapeutic targets in desmoplastic small round cell sarcoma (DSRCT)
Home institute: National Cancer Center Research Institute, Tokyo, Japan
Host institute: Institut Gustave Roussy, Villejuif, France
Sponsor: ESMO
Start date: November 2019 (prolonged for the 2nd year)

Ignacio Matos Garcia
matos-ignacio

Project: Impact of human FCγR gene polymorphism on hyper-progression disease with anti-PD1 inhibitors based on Antibody mediated PD1+ T cell phagocytosis
Home institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Host institute: UCL Cancer Institute, London, United Kingdom
Sponsor: Roche
Start date: February 2021 (prolonged for the 2nd year)

Laura Mezquita Pérez
mezquita-perez-laura

Project: RADAR study: Molecular signature of radioactivity-induced lung cancer based on radon-induced lung cancer in rats from the French Atomic Energy Commission cohort 
Home institute: Institut Gustave Roussy, Villejuif, France
Host institute: Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
Sponsor: BMS
Start date: January 2020 (prolonged for the 2nd year)

Mariela Vasileva-Slaveva
vasileva-slaveva-mariela

Project: Breast cancer metastasis and lipid metabolism implication
Home institute: Alexandrovska University Hospital, Sofia, Bulgaria
Host institute: Innsbruck Medical University, Austria
Sponsor: ESMO
Fellowship period: Novemeber 2019 – October 2020

Giacomo Bregni
bregni-giacomo

Project: A phase II trial of neoadjuvant regorafenib in combination with nivolumab and short-course radiotherapy in intermediate-risk, stage II-III rectal cancer (REGINA)
Home institute: Ospedale Policlinico S. Martino IRCCS, Genoa, Italy
Host institute: Institut Jules Bordet, Brussels, Belgium
Sponsor: ESMO
Start date: January 2020 (prolonged for the 2nd year)

Carlo Cattrini
cattrini-carlo

Project: BRCA2MEN: an international, multicentre, observational and ambispective study to validate the predictive value of germline BRCA2 mutations in selecting first-line metastatic castration-resistant prostate cancer (mCRPC) treatment
Home institute: San Martino Polyclinic Hospital, Italy
Host institute: National Cancer Research Center (CNIO), Madrid, Spain
Sponsor: ESMO
Fellowship period: January 2020 – January 2021

2018

Michael-John Devlin
devlin-michael-john

Project: The Immune Microenvironment of a Murine Model of Clear Cell Ovarian Cancer
Home institute: University College Londo Hospital, London, United Kingdom
Host institute: Institute, Queen Mary University of London, London, United Kingdom
Sponsor: Roche
Fellowship period: September 2018 – August 2019

Elisa Gobbini
gobbibi-elisa

Project: Role of BDCA3high dendritic cells and type III interferon in anti-tumor immune responses
Home institute: Azienda Ospedaliera Universitaria San Luigi Gonzaga, Orbassano, Italy
Host institute: Léon Bérard research center, Lyon, France
Sponsor: BMS
Fellowship period: September 2018 – September 2020

Christoph Oing
oing-christoph

Project: Illuminating the genomic landscape of hypoxia-driven early metastatic prostate cancer
Home institute: University Medical Center Hamburg-Eppendorf, Germany
Host institute: Manchester Cancer Research Centre, Manchester, United Kingdom
Sponsor: Roche
Fellowship period: September 2018 – September 2019

Download the report

Federica Papaccio
papaccio-federica

Project: Development of “living organoid biobank” derived from colorectal cancer patients. Towards a personalized medicine in cancer
Home institute: Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy
Host institute: INCLIVA Biomedical Research Institute, Department of Medical Oncology, Hospital Clinico Universitario de Valencia
Sponsor: Amgen
Fellowship period: September 2018 – September 2020

Daniel Eiger
eiger-daniel

Project: Cardiotoxicity Related to Systemic Anti-HER2 Therapies: sub-analysis of ALTTO and APHINITY trials
Home institute: Centro Paulista de Oncologia, Sao Paolo, Brazil
Host institute: Institute Jules Bordet, Brussels, Belgium
Sponsor: Novartis
Fellowship period: September 2018 – September 2019

Download the report

Read the publication

2017

Angelika Bezan
bezan-angelika

Project: Liquid biopsy by apheresis
Home institute: Medical University of Graz, Austria
Host institute: Institute of Cancer Research, The Royal Marsden, Sutton, United Kingdom
Sponsor: Roche
Fellowship period: October 2017 – October 2018

Giulia Martini
martini-giulia

Project: An integrative bedside to bench approach for discovery and validation of new biomarkers of resistance in metastatic Colorectal Cancer (mCRC) by liquid biopsy and development of preclinical cancer models
Home institute: Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy
Host institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Sponsor: Amgen
Fellowship period: October 2017 – October 2019

Bernadetta Pellegrino
pellegrino-benedetta

Project: Exploiting the DNA-damage response upon PARP inhibition in homologous recombination deficient tumors to maximize the activity of anti-PD-L1 therapy
Home institute: Azienda Ospedaliera di Parma, Italy
Host institute: Vall d'Hebron Institute of Oncology, Barcelona, Spain
Sponsor: Roche
Fellowship period: July 2018 – July 2019

Download the report

Antonio Di Meglio
di-meglio-antonio

Project: Health Behaviors and Long-term Treatment Toxicity Among Breast Cancer Survivors: A Quantitative Analysis in the French Prospective CANTO Cohort
Home Institute: IRCCS AOU San Martino, Genoa, Italy
Host institute: Institut Gustave Roussy, Villejuif, France
Sponsor: ESMO
Fellowship period: September 2017 – September 2018

Bruno Duso
duso-bruno

Project: A Phase I-II Investigation of Pembrolizumab in Combination with Oral Metronomic Cyclophosphamide in Patients with Locally Recurrent, Inoperable, and/or Metastatic Inflammatory Breast Cancer with Lymphangitic Spread to the Chest Wall
Home Institute: Hospital Moinhos de Vento, Porto Alegre, Brazil
Host institute: Istituto Europeo di Oncologia, Milan, Italy
Sponsor: ESMO
Fellowship period: August 2017 – August 2018

Download the report

Sheraz Markar
markar-sheraz

Project: Lasting Symptoms after Esophageal Resection (LASER) 
Home Institute: St. Mary's Hospital Imperial College, London, United Kingdom
Host institute: Karolinska Instituttet, Stockholm, Sweden
Sponsor: Novartis
Fellowship period: September 2017 – September 2018

2016

Annalisa Milano
milano-annalisa

Project: Next-generation expression analysis (NanoString) to develop prognostic and predictive gene signatures for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Home institute: St. Andrea Hospital, Medical and Surgical Sciences and Translational Medicine, Rome, Italy
Host institute: Agostino Gemelli Hospital, Rome, Italy
Sponsor: Roche
Fellowship period: October 2016 – November 2018

Francesca Maria Rizzo
rizzo-francesca-maria

Project: Different expression of CXCR4 on CTCs from NET patients with or without skeletal metastases
Home institute: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Department of Biomedical Sciences and Human Oncology, Bari, Italy
Host institute: UCL Cancer Institute – Department of Oncology, London, United Kingdom
Sponsor: Roche
Fellowship period: August 2016 – September 2018

Sarah Kammerer
kammerer-sarah

Project: Clear Cell Renal Cell Carcinoma: development of novel treatment strategies targeting cancer stem cells and identification of new predictive biomarkers
Home institute: Medical University Graz, Institute of Biophysics, Graz, Austria
Host institute: Max Delbrück Centrum for Molecular Medicine (MDC), Berlin, Germany
Sponsor: Amgen
Fellowship period: September 2016 – September 2017

Download the report

Matteo Lambertini 
lambertini-matteo

Project: Liquid Biomarkers during Fertility Preserving Procedures in BRCA Mutated Breast Cancer Patients
Home Institute: IRCCS AOU San Martino - IST, Genova, Italy
Host institute: Jules Bordet Institute, Breast Cancer Translational Research Laboratory, Brussels, Belgium
Sponsor: Amgen
Fellowship period: August 2016 – August 2018

Read the publication

Piera Gargiulo
gargiulo-piera

Project: Inflammation markers and prognostic model of survival and toxicity in patients with advanced pancreatic cancer (APC) receiving palliative Gemcitabine-based chemotherapy: insights from the SAKK 44/00-CECOG/PAN.1.3.001
Home institute: Istituto Nazionale Tumori- I.R.C.C.S - Fondazione Pascale, Napoli, Italy
Host institute: Swiss Group for Clinical Cancer Research SAKK, Bern, Switzerland
Sponsor: Novartis
Fellowship period: July 2016 – October 2017

Download the report

Read the publication

2015

Lisa Derosa 
derosa-lisa

Project: BRAVE - Brain metastases and pancReatic metastases: A clinicopathological comparison of Various facets of the tumour hEterogeneity in renal cell carcinoma
Home Institute: Azienda Ospedaliero, Universitaria S.Chiara, Pisa, Italy
Host Institute: Institut Gustave Roussy, Villejuif, France
Sponsor: Roche
Fellowship period: November 2015 – November 2017

Download the report

Zoltan Lohinai
lohinai-zoltan

Project: The role of blood and lymph vessels in malignant pleural mesothelioma: From biology to therapy
Home Institute: National Koranyi Institute of Pulmonology, Budapest, Hungary
Host Institute: Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Austria
Sponsor: Roche
Fellowship period: August 2015 – August 2017

Download the report

Blanca Navarro Rodrigo
navarro-rodrigo-blanca

Project: Targeting mutational signatures in colorectal cancer
Home Institute: INCLIVA - University of Valencia, Spain
Host Institute: University Hospital of Lausanne, Ludwig Cancer Research Center, Switzerland
Sponsor: Amgen
Fellowship period: October 2015 – October 2017

Petr Szturz
szturz-petr

Project: Evaluation of MET expression and inhibition in squamous cell carcinomas of the head and neck
Home Institute: University Hospital Brno, Czech Republic
Host Institute: Hopital Bichat - Claude Bernand, Paris, France
Sponsor: Amgen
Fellowship period: November 2015 – November 2016

Download the report

Alberto Verlicchi
verlicchi-alberto

Project: Therapeutic opportunities for Squamous cell carcinoma of the lung: the Hedghog pathway and beyond
Home Institute: Ospedale Civile di Ravenna, Italy
Host Institute: Germans Trias i Pujol, Barcelona, Spain
Sponsor: Roche
Fellowship period: September 2015 – September 2016

Download the report

Sara Valpione
valpione-sara

Project: Study of prognostic factors in patients with BRAF-mutant metastatic melanoma treated with targeted therapies
Home Institute: University of Padova, Italy
Host Institute: The Christie NHS Foundation Trust, University of Manchester, United Kingdom
Sponsor: Novartis
Fellowship period: October 2015 – October 2016

 

2014

Vincenza Conteduca
conteduca-vincenza

Project: Novel biological profiles of sensitivity and/or resistance to Abiraterone and/or Enzalutamide in patients with castration-resistant prostate cancer
Home Institute: Istituto Tumori della Romagna I.R.S.T., Meldola, Italy
Host Institute: The Institute of Cancer Research, Sutton, United Kingdom
Sponsor: Roche
Fellowship period: October 2014 – October 2016

Download the report

Valentina Gambardella
Valentina Gambardella

Project: The Role of MET in Primary and Acquired Resistance in HER2 positive gastric cancer
Home Institute: AOU Seconda Università degli Studi di Napoli (AOU-SUN), Napoli, Italy
Host Institute: INCLIVA Biomedical Research Institute, Department of Hematology and Medical Oncology, Hospital Clinico de Valencia, University of Valencia, Spain
Sponsor: Amgen
Fellowship period: October 2014 – October 2016

Colin Lindsay
Colin Lindsey

Project: Assessing the clinical application of circulating tumour cells in non-small cell lung cancer using therapeutic apheresis
Home Institute: Beatson West of Scotland Cancer Centre Gartnavel General Hospital, Glasgow, United Kingdom
Host Institute: Institut de Cancérologie Gustave Roussy, Villejuif, France
Sponsor: Roche
Fellowship period: November 2014 – November 2016

Download the report

Amir Sonnenblick
Amir Sonnenblick

Project: Phsophorylated-STAT3 and trastuzumab resistance
Home Institute: The Hebrew University of Jerusalem- Hadassah Medical Center, Jerusalem, Israel
Host Institute: Institut Jules Bordet, Brussels, Belgium
Sponsor: Roche
Fellowship period: July 2014 – December 2015

Download the report

Michael Kolinsky
Michael Kolinsky

Project: Co-targeting of AKT and the Androgen Receptor for Advanced Prostate Cancer
Home Institute: University of Alberta Cross Cancer Institute, Edmonton, Alberta, Canada
Host Institute: The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK
Sponsor: Novartis
Fellowship period: October 2014 – December 2015

 

2013

Antoine Hollebecque
Antoine Hollebecque

Project: Circulating Nucleic Acids as predictive biomarkers in Advanced Cancer Patients
Home Institute: Institut Gustave Roussy, Department of Medicine SITEP, Villejuif, France
Host Institute: Paterson Institute for Cancer Research, The University of Manchester, United Kingdom
Sponsor: Roche
Fellowship period: November 2013 – November 2014 

Noelia Tarazona Llavero
Noelia Tarazona

Project: FGFR2 in gastroesophageal cancer: prognosis, prediction and the effects of therapeutic intervention
Home Institute: Hospital Clinico Universitario de Valencia, Department Haematology and Medical Oncology, Valencia, Spain
Host Institute: The Royal Marsden NHS Foundation Trust, London, United Kingdom
Sponsor: Roche
Fellowship period: October 2013 - October 2015

Download the report

Daniela Morales-Espinosa
Daniela Morales Espinosa

Project: Characterization and potential clinical implications of the replication pathway in lung cancer
Home Institute: Instituto Nacional de Cancerología, Department: Clinical and Basic Research Sub-direction , Mexico City, Mexico
Host Institute: Catalan Institute of Oncology, Badalona, Barcelona, Spain
Sponsor: Roche
Fellowship period: August 2013 – August 2015

Aysegül Ilhan-Mutlu
Aysegul Ilhan-Mutlu

Project: Prevention of Brain Metastasis of Non-Squamous Non-Small Cell Lung Cancer By Antiangiogenic Therapy In Mice
Home Institute: Vienna General Hospital (AKH) - Medical University of Vienna, Department of Oncology, Vienna, Austria
Host Institute: University Clinic Heidelberg/Germany, German Cancer Research Centre, Heidelberg, Germany
Sponsor: Amgen
Fellowship period: October 2013 – September 2014 

Download the report

Tal Grenader
Tal Grenader

Project: Molecular resistance following personalised therapy in colorectal cancer (FOCUS-4 clinical fellow)
Home Institute: Shaare Zedek Medical Centre, Jerusalem, Israel
Host Institute: UCL, Cancer Institute, University College London, United Kingdom
Sponsor: Novartis
Fellowship period: November 2013 – November 2014

Guillermo Antonio De Velasco Oria
Guillermo Antonio De Velasco Oria

Project: Metabolomic study in renal cell carcinoma (RCC): patterns of relapsed and follow up
Home Institute: University Hospital 12 De Octubre, Medical Oncology, Madrid, Spain
Host Institute: Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Sponsor: Novartis
Fellowship period: September 2013 – August 2014  

2012

Claudette Falato  
Claudette Falato

Project: Prognostic and predictive role of Ki67 determined on metastatic tissue of patients with advanced breast cancer
Home Institute: National Cancer Institute, Naples, Italy
Host institute: Karolinska University Hospital, Stockholm, Sweden
Sponsor: Roche
Fellowship period: April 2013 – March 2014

Jennifer Gibbons Marsico
Jennifer Gibbons Marsico

Project: Metabolomic and pharmacological patterns of resistance to the tyrosine kinase inhibitor sunitinib in patients with advanced renal-cell cancer
Home Institute: Instituto Nacional del Cancer (INCA), Montevideo, Uruguay
Host institute: Kantonsspital St Gallen, Switzerland
Sponsor: Roche
Fellowship period: January 2013 – Novemeber 2014

Angela Lamarca
lamarca-angela

Project: Feasibility evaluation of proliferation and nucleoside transport using FLT PET imaging in advanced pancreatic cancer patients
Home Institute: Hospital Universitario La Paz, Madrid, Spain
Host institute: The Christie NHS Foundation Trust, Manchester, UK
Sponsor: Amgen
Fellowship period: January 2013 – January 2015

Download the report

Elisabetta Pietri
Elisabetta Pietri

Project: Characterisation of individual foci of multicentric/multifocal breast cancer
Home institute: Istituto Tumori della Romagna I.R.S.T. , Meldola, Italy
Host institute: Institut Jules Bordet - Breast Cancer Translational Research Laboratory, Brussels, Belgium 
Sponsor: Amgen
Fellowship period: October 2012 – April 2014 

Loredana Vecchione
Loredana Vecchione

Project: Identification of multiple synthetic lethal interactions with the BRAF oncogene in colorectal cancer
Home institute: Katholieke Universities Leuven - Gasthuisberg University Hospital, Leuven, Belgium
Host institute: Department of Molecular Carcinogenesis B7 - NKI - Antoni van Leeuwenhoek Ziekenhuis - Prof Rene Bernards, Amsterdam, The Netherlands
Sponsor: Roche
Fellowship period: September 2013 – August 2014

2011

Daniela Kolarevic
Daniela Kolarevic

Project: Identification and validation of targeted Therapeutics in triple negative breast cancer (Translational Research within Neobig programme)
Home institute: Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
Host institute: Breakthrough Breast Cancer Research Unit, Guy's and St. Thomas Hospital, London, UK
Sponsor: Roche
Fellowship period: 2011 (prolonged for a further year)

Sophie Postel-Vinay
Sophie Postel-Vinay

Project: Investigation of DNA repair deficiencies in Non Small Cell Lung Cancer and therapeutic applications using synthetic lethality
Home institute: Institut Gustave Roussy, Paris, France
Host institute: The Institute of Cancer Research, London, UK
Sponsor: Roche
Fellowship period: 2011 (prolonged for a further year)

Alejandra Armengol Alonso
 Alejandra Alonso

Project: Association between insulin resistance and pathologic response to neoadjuvant chemotherapy among women with operable hormone receptor negative breast cancer
Home Institute: Instituto Nacional De Ciencias Medicias y Nutricion, Mexico City, Mexico
Host Institute: Barcelona Hospital Universitari, Barcelona, Spain
Sponsor: Novartis
Fellowship period: March 2012 – February 2013

Download the report

2010

Leticia De Mattos-Arruda
Leticia De Mattos Arruda

Project: Circulating tumour cells in metastatic breast cancer: it is time to detect and genotyping
Home institute: Santa Casa de Misericórdia de Belo Horizonte, Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brazil
Host institute: Vall d´Hebron University Hospital, Barcelona, Spain
Sponsor: Amgen
Fellowship period: August 2010 – August 2012 

Download the report

Hatem Azim
Hatem Azim

Project: Genomic Profiling of Breast Cancer diagnosed during pregnancy
Home institute: National Cancer Institute, Cairo Oncology Centre, Mohandeseen, Egypt
Host institute: Jules Bordet Institute, Brussels, Belgium 
Sponsor: Roche
Fellowship period: October 2010 – September 2012 

Download the report

Konstantinos-Vellios Kamposioras
Konstantinos Kamposioras

Project: Molecular characterisation of the stromal microenvironment in pancreatic adenocarcinoma and its role in tumour progression and prognosis
Home institute: University Hospital of Larissa, Greece
Host institute: St. James Institute of Oncology Level 4, Bexley Wing, St. James University Hospital, Leeds, UK
Sponsor: Roche
Fellowship period: 2011 – 2013 

Download the report

Michalis Karamouzis
karamouzis-michalis

Project: Molecular and genetic analysis of stromal fibroblasts in prostate cancer
Home institute: Medical School, University of Athens, Greece
Host institute: Department of Biological Chemistry, Medical School, University of Athens, Greece
Sponsor: Amgen
Fellowship period: 2010 – 2011  

Download the report

Giulia Pasello

Project: Identification of novel molecular targets and biological agents for the chemotherapy of malignant Pleural Mesothelioma
Home institute: Second Medical Oncology Unit, Instituto Oncologico Veneto, Padova Italy
Host institute: Department of Oncological and Surgical Sciences, Oncology Section, Istituto Oncologico Veneto, Padova, Italy
Sponsor: Roche
Fellowship period: July 2010 – July 2012

Download the report

Karin Tamas

Project: Exploring the tumour microenvironment with focus on Placental growth factor and colorectal cancer
Home institute: Szent Laszlo Teaching Hospital, Budapest, Hungary
Host institute: University Medical Center Groningen, The Netherlands
Sponsor: Roche
Fellowship period: September 2010 – September 2012 

Download the report

Teresa Troiani
Teresa Troiani

Project: Use of MEK inhibitors to overcome primary and acquired resistance to anti-EGFR therapies
Home institute: Oncologia Medica, Seconda Università Degli Studi di Napoli, Dipartimento di Internistica Clinica e Sperimentale "F. Magrassie E Lanzara", Naples, Italy
Host institute: Oncologia Medica, Seconda Università Degli Studi di Napoli, Dipartimento di Internistica Clinica e Sperimentale "F. Magrassie E Lanzara", Naples, Italy
Sponsor: Amgen
Fellowship period: August 2010 – August 2011

Michael Baumann

Project: Treatment of naïve and fludarabine-refractory CLL in the TCL-1 mouse model with IPI-926 and other hedgehog pathway inhibitors
Home Institute: Department of Medical Oncology, Kantonsspital, St. Gallen, Switzerland
Host Institute:Laboratory of Molecular Biology and Immunology CLL, Dept of Haematology and Oncology, University of Cologne, Germany
Sponsor: ESMO
Fellowship period: October 2010 – September 2011 

Download the report

Elena Castro Marcos

Project: Prostate Cancer Genetics and targeted screening
Home Institute: Centro de Investigacion del Cancer, Hospital Universitario de Salamanca, Spain
Host Institute: Royal Marsden Hospital NHS Trust, and The institute of Cancer Research, London, United Kingdom
Sponsor: Novartis
Fellowship period: October 2010 – September 2011 

Download the report

Last update: August 2021

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings